Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7834]
Articles [63]
Editorials [9]
Conferences [210]
elearning [49]
Key lymphoma research from ASH 2010
Prof Wyndham Wilson - National Cancer Institute, Maryland, USA
Key lymphoma research from ASH 2010 ( Prof Wyndham Wilson - National Cancer Institute, Maryland, USA )
18 Feb 2011
ENESTnd trial comparing nilotinib and imatinib as first line CML therapy
Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide...
ENESTnd trial comparing nilotinib and imatinib as first line CML therapy ( Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia )
18 Feb 2011
Signalling pathways as a target for cancer therapies
Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK
Signalling pathways as a target for cancer therapies ( Prof Mariann Bienz - MRC Laboratory of Molecular Biology, Cambridge, UK )
14 Feb 2011
Inotuzumab ozogamicin therapy for indolent B-cell non-Hodgkin's lymphoma
Prof Andre Goy - Hackensack University Medical Center, New Jersey, USA
Inotuzumab ozogamicin therapy for indolent B-cell non-Hodgkin's lymphoma ( Prof Andre Goy - Hackensack University Medical Center, New Jersey, USA )
13 Feb 2011
Temsirolimus and clofarabine for the treatment of elderly AML patients
Prof Sergio Amadori - Tor Vergata University Hospital, Rome, Italy
Temsirolimus and clofarabine for the treatment of elderly AML patients ( Prof Sergio Amadori - Tor Vergata University Hospital, Rome, Italy )
13 Feb 2011
Ofatumumab treatment for chronic lymphocytic leukaemia
Dr William Wierda - University of Texas, USA
Ofatumumab treatment for chronic lymphocytic leukaemia ( Dr William Wierda - University of Texas, USA )
13 Feb 2011
Role of bortezomib in the treatment of follicular lymphoma
Prof Bertrand Coiffier - Hospices Civils de Lyon, France
Role of bortezomib in the treatment of follicular lymphoma ( Prof Bertrand Coiffier - Hospices Civils de Lyon, France )
13 Feb 2011
Denosumab treatment of skeletal related events
Prof Allan Lipton - Hershey Medical Center, Pennsylvania, USA
Denosumab treatment of skeletal related events ( Prof Allan Lipton - Hershey Medical Center, Pennsylvania, USA )
8 Feb 2011
The Spectrum Study
Prof Jan Vermorken – Antwerp University Hospital, Edegem, Belgium
The Spectrum Study ( Prof Jan Vermorken – Antwerp University Hospital, Edegem, Belgium )
8 Feb 2011
Treatment of brain metastases in melanoma patients
Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander...
Treatment of brain metastases in melanoma patients ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands )
7 Feb 2011
The role of bevacizumab in the treatment of ovarian cancer
Dr Amit Oza - Princess Margaret Hospital, Toronto, Cancada; Dr Robert Burger...
The role of bevacizumab in the treatment of ovarian cancer ( Dr Amit Oza - Princess Margaret Hospital, Toronto, Cancada; Dr Robert Burger - Fox Chase Cancer Center, Philadelphia, USA; Prof Nicoletta Colombo - European Institute of Oncology, Milan, Italy )
7 Feb 2011
Sarah Cannon Research Institute research developments at ASCO 2010
Dr Howard Burris, The Sarah Cannon Research Institute, Nashville
Sarah Cannon Research Institute research developments at ASCO 2010 ( Dr Howard Burris, The Sarah Cannon Research Institute, Nashville )
4 Feb 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation